Skip to Main Content

Author Details

Andrea Sboner
Institute for Computational Biomedicine
2000
153
56
PMIDPaper TitleJournal TitlePublished Year
37676819Molecular features of prostate cancer after neoadjuvant therapy in the phase 3 CALGB 90203 trial.J Natl Cancer Inst2024
37676819Molecular features of prostate cancer after neoadjuvant therapy in the phase 3 CALGB 90203 trial.J Natl Cancer Inst2024
37652664The importance of escalating molecular diagnostics in patients with low-grade pediatric brain cancer.Cold Spring Harb Mol Case Stud2024
38047392NIPBL::NACC1 Fusion Hepatic Carcinoma.Am J Surg Pathol2024
37652664The importance of escalating molecular diagnostics in patients with low-grade pediatric brain cancer.Cold Spring Harb Mol Case Stud2024
38047392NIPBL::NACC1 Fusion Hepatic Carcinoma.Am J Surg Pathol2024
35968961GLI1 -Rearranged Enteric Tumor : Expanding the Spectrum of Gastrointestinal Neoplasms With GLI1 Gene Fusions.Am J Surg Pathol2023
35968961GLI1 -Rearranged Enteric Tumor : Expanding the Spectrum of Gastrointestinal Neoplasms With GLI1 Gene Fusions.Am J Surg Pathol2023
37919447Author Correction: Evolution of structural rearrangements in prostate cancer intracranial metastases.NPJ Precis Oncol2023
37704749Evolution of structural rearrangements in prostate cancer intracranial metastases.NPJ Precis Oncol2023
36480186The Cytidine Deaminase APOBEC3G Contributes to Cancer Mutagenesis and Clonal Evolution in Bladder Cancer.Cancer Res2023
36796016Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL.Blood2023
36453641Paired bone marrow and peripheral blood samples demonstrate lack of widespread dissemination of some CH clones.Blood Adv2023
37489101Whole-genome Analysis Elucidates Complex Genomic Events in GLI1 -rearranged Enteric Tumor.Am J Surg Pathol2023
37223924Immunogenomic Landscape of Neuroendocrine Prostate Cancer.Clin Cancer Res2023
37919447Author Correction: Evolution of structural rearrangements in prostate cancer intracranial metastases.NPJ Precis Oncol2023
37489101Whole-genome Analysis Elucidates Complex Genomic Events in GLI1 -rearranged Enteric Tumor.Am J Surg Pathol2023
37704749Evolution of structural rearrangements in prostate cancer intracranial metastases.NPJ Precis Oncol2023
37223924Immunogenomic Landscape of Neuroendocrine Prostate Cancer.Clin Cancer Res2023
36480186The Cytidine Deaminase APOBEC3G Contributes to Cancer Mutagenesis and Clonal Evolution in Bladder Cancer.Cancer Res2023
36796016Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL.Blood2023
36453641Paired bone marrow and peripheral blood samples demonstrate lack of widespread dissemination of some CH clones.Blood Adv2023
34483300Molecular Evaluation of Low-grade Low-stage Endometrial Cancer With and Without Recurrence.Int J Gynecol Pathol2022
35510953Inhibition of FGF receptor blocks adaptive resistance to RET inhibition in CCDC6-RET-rearranged thyroid cancer.J Exp Med2022
35617398Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets.Science2022
35726553Transcriptional and metabolic remodeling in clear cell renal cell carcinoma caused by ATF4 activation and the integrated stress response (ISR).Mol Carcinog2022
35475276Utility of multimodality molecular profiling for pediatric patients with central nervous system tumors.Neurooncol Adv2022
36121736African Ancestry-Associated Gene Expression Profiles in Triple-Negative Breast Cancer Underlie Altered Tumor Biology and Clinical Outcome in Women of African Descent.Cancer Discov2022
36577525Whole-genome characterization of myoepithelial carcinomas of the soft tissue.Cold Spring Harb Mol Case Stud2022
35231161The genomic landscape of metastatic clear cell renal cell carcinoma after systemic therapy.Mol Oncol2022
35189355Containers in Bioinformatics: Applications, Practical Considerations, and Best Practices in Molecular Pathology.J Mol Diagn2022
34483300Molecular Evaluation of Low-grade Low-stage Endometrial Cancer With and Without Recurrence.Int J Gynecol Pathol2022
34999736Elevated expression of the colony-stimulating factor 1 (CSF1) induces prostatic intraepithelial neoplasia dependent of epithelial-Gp130.Oncogene2022
35220606Comparative genomics of primary prostate cancer and paired metastases: insights from 12 molecular case studies.J Pathol2022
35617398Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets.Science2022
35510953Inhibition of FGF receptor blocks adaptive resistance to RET inhibition in CCDC6-RET-rearranged thyroid cancer.J Exp Med2022
35475276Utility of multimodality molecular profiling for pediatric patients with central nervous system tumors.Neurooncol Adv2022
35726553Transcriptional and metabolic remodeling in clear cell renal cell carcinoma caused by ATF4 activation and the integrated stress response (ISR).Mol Carcinog2022
36577525Whole-genome characterization of myoepithelial carcinomas of the soft tissue.Cold Spring Harb Mol Case Stud2022
36121736African Ancestry-Associated Gene Expression Profiles in Triple-Negative Breast Cancer Underlie Altered Tumor Biology and Clinical Outcome in Women of African Descent.Cancer Discov2022
35189355Containers in Bioinformatics: Applications, Practical Considerations, and Best Practices in Molecular Pathology.J Mol Diagn2022
35220606Comparative genomics of primary prostate cancer and paired metastases: insights from 12 molecular case studies.J Pathol2022
34999736Elevated expression of the colony-stimulating factor 1 (CSF1) induces prostatic intraepithelial neoplasia dependent of epithelial-Gp130.Oncogene2022
35231161The genomic landscape of metastatic clear cell renal cell carcinoma after systemic therapy.Mol Oncol2022
32948110Limitations of Detecting Genetic Variants from the RNA Sequencing Data in Tissue and Fine-Needle Aspiration Samples.Thyroid2021
34286887Validation of a Circulating Tumor DNA-Based Next-Generation Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma Testing.Oncologist2021
34168263Androgen receptor variant shows heterogeneous expression in prostate cancer according to differentiation stage.Commun Biol2021
33851193Social and Clinical Determinants of COVID-19 Outcomes: Modeling Real-World Data from a Pandemic Epicenter.medRxiv2021
33998599Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer.J Clin Invest2021
33568750Molecular medicine tumor board: whole-genome sequencing to inform on personalized medicine for a man with advanced prostate cancer.Prostate Cancer Prostatic Dis2021
  • 1 - 50 of 306

Recommended Authors

Job van Riet
Erasmus MC Cancer Institute
Career Start Year 2017
Number of shared co-authors 5
Daniel Vod??k
Institute for Cancer Research, Oslo University Hospital
Career Start Year 2014
Number of shared co-authors 9
Emilie Lalonde
University of Pennsylvania
Career Start Year 2010
Number of shared co-authors 9
David A Quigley
University of California-San Francisco
Career Start Year 2008
Number of shared co-authors 39
Xinmin Li
University of California los angeles
Career Start Year 2008
Number of shared co-authors 4
Siyuan Zheng
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 18
Christopher A Maher
Washington University in St Louis
Career Start Year 2006
Number of shared co-authors 57
David C Wedge
Manchester Cancer Research Centre, University of Manchester
Career Start Year 2006
Number of shared co-authors 12
Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 30
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 11
Svitlana Tyekucheva
Dana-Farber Cancer Institute
Career Start Year 2006
Number of shared co-authors 24
Markus Riester
Novartis Institutes for BioMedical Research
Career Start Year 2005
Number of shared co-authors 11
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 15
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 3
Matthew D Wilkerson
Uniformed Services University of the Health Sciences
Career Start Year 2004
Number of shared co-authors 21
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 3
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 5
Obi L Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 15
Peter Van Loo
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 9
Daniel S Brewer
University of Washington, USA Institute for Stem Cell and Regenerative Medicine
Career Start Year 2003
Number of shared co-authors 15
Syed Haider
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 17
Vladimir Makarov
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 27
Luciano G Martelotto
Monash University
Career Start Year 2000
Number of shared co-authors 12
Yan W Asmann
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 8
Paul T Spellman
Oregon Health & Science University Hospital.
Career Start Year 1998
Number of shared co-authors 13
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 35
John V Pearson
QIMR Berghofer Medical Research Institute
Career Start Year 1996
Number of shared co-authors 9
Adam B Olshen
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 16
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 28
Paul C Boutros
University of California los angeles
Career Start Year 1970
Number of shared co-authors 92

Collaborators

Mark A Rubin
University of Bern
Co-authored papers 70
Olivier Elemento
Meyer Cancer Center
Co-authored papers 57
Himisha Beltran
Dana-Farber Cancer Institute
Co-authored papers 56
Juan Miguel Mosquera
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 53
Francesca Demichelis
University of Trento
Co-authored papers 45
Rohan Bareja
Case Western Reserve University
Co-authored papers 27
Brian D Robinson
Sandra and Edward Meyer Cancer Center
Co-authored papers 26
Mark Gerstein
Yale University
Co-authored papers 23
Christopher E Barbieri
Weill Cornell Medical College
Co-authored papers 23
David M Nanus
Sandra and Edward Meyer Cancer Center
Co-authored papers 23
Kenneth Eng
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 23
Michael Sigouros
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 22
Scott T Tagawa
Meyer Cancer Center, Weill Cornell Medicine-NewYork Presbyterian Hospital
Co-authored papers 22
Davide Prandi
University of Trento
Co-authored papers 16
Joanna Cyrta
Paris Sciences Lettres University PSL, Institut CURIE
Co-authored papers 14
Yu Chen
School of Pharmacy, University of Wisconsin-Madison
Co-authored papers 14
David Wilkes
Caryl and Israel Englander Institute for Precision Medicine.
Co-authored papers 13
Theresa Y MacDonald
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 13
David S Rickman
Meyer Cancer Center
Co-authored papers 12
Alessandro Romanel
University of Trento
Co-authored papers 12
Bishoy M Faltas
Sandra and Edward Meyer Cancer Center
Co-authored papers 12
Loredana Puca
Sandra and Edward Meyer Cancer Center
Co-authored papers 12
Levi A Garraway
Broad Institute of Harvard and MIT
Co-authored papers 11
Alexandros Sigaras
Columbia University, United States Bureau of Educational and Cultural Affairs Fulbright Program, University of Piraeus, Weill Cornell Medical College, Weill Cornell Medicine
Co-authored papers 11
Kyung Park
New York University Langone Health
Co-authored papers 11
Charles L Sawyers
Memorial Sloan Kettering Cancer Center
Co-authored papers 10
Chantal Pauli
University Hospital Zurich
Co-authored papers 10
Jenny Xiang
Caryl and Israel Englander Institute for Precision Medicine.
Co-authored papers 10
Arul M Chinnaiyan
University of Michigan Medical School.
Co-authored papers 10
Philip W Kantoff
Memorial Sloan Kettering Cancer Center
Co-authored papers 9
Release 1.2